Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Journal of Huazhong University of Science and Technology (Medical Sciences) ; (6): 368-371, 2016.
Article Dans Anglais | WPRIM | ID: wpr-285261

Résumé

Although the development of the 2009 SpA classification criteria by Assessment of SpondyloArthritis international Society (ASAS) represents an important step towards a better definition of the early disease stage particularly in axial spondyloarthritis (axSpA), the specificity of the criteria has been criticized these days. As the commonest zoonotic infection worldwide, human brucellosis can mimic a large number of diseases, including SpA. This study was performed to determine the frequency of rheumatologic manifestations in patients with brucellosis and the chance of misdiagnosing them as having axSpA in central China. The results showed that clinical manifestations of axSpA could be observed in brucellosis. Over half of patients had back pain, and one fifth of the patients with back pain were less than 45 years old at onset and had the symptom for more than 3 months. Two young males were falsely classified as suffering from axSpA according to the ASAS criteria, and one with MRI proved sacroiliitis was once given Etanercept for treatment. Therefore, differential diagnosis including human brucellosis should always be kept in mind when applying the ASAS criteria, even in traditionally non-endemic areas.


Sujets)
Adulte , Sujet âgé , Femelle , Humains , Mâle , Adulte d'âge moyen , Antirhumatismaux , Utilisations thérapeutiques , Dorsalgie , Brucellose , Diagnostic , Traitement médicamenteux , Chine , Diagnostic différentiel , Erreurs de diagnostic , Étanercept , Utilisations thérapeutiques , Prescription inappropriée , Guides de bonnes pratiques cliniques comme sujet , Rhumatologues , Éthique , Sacro-iliite , Spondylarthrite , Diagnostic , Traitement médicamenteux
SÉLECTION CITATIONS
Détails de la recherche